Mode
Text Size
Log in / Sign up
N/A Completed N=42 Randomized Double-blind Treatment

Comparison of Robot-Assisted Gait Training and Conventional Therapy in Multiple Sclerosis Patients

Source: ClinicalTrials.gov NCT03801473 ↗
Enrolled (actual)
42
Serious AEs
Results posted
Feb 2021
Primary outcomePrimary: Fatigue Severity Score — 5.5; 6 score on a scale

Summary

The aim of this study is to compare conventional neurorehabilitation with robot-assisted gait training program in terms of fatigue, anxiety, depression and quality of life.

Outcome Measures

OutcomeResultp-value
PRIMARY
Fatigue Severity Score
5.5; 5.7
PRIMARY
Hospital Anxiety Depression Scale-Depression Subscale (HADS-D)
8.5; 10
PRIMARY
Hospital Anxiety Depression Scale- Depression Subscale (HADS-D)
6.5; 9
PRIMARY
Hospital Anxiety Depression Scale- Anxiety Subscale (HADS-A)
7.5; 8
PRIMARY
Hospital Anxiety Depression Scale-Anxiety Subscale (HADS-A)
5; 8
SECONDARY
Multiple Sclerosis Quality of Life-54 (MSQOL-54)-Physical Health
34.2; 33.7
SECONDARY
Multiple Sclerosis Quality of Life-54 (MSQOL-54)- Physical Health
32.9; 29.1
SECONDARY
Expanded Disability Status Scale (EDSS)
6; 6
SECONDARY
Functional Ambulation Classification
1; 1
SECONDARY
Walking Ability
60; 65
SECONDARY
Berg Balance Test (BBT)
23; 18

Eligibility Criteria

Inclusion Criteria

  • 18-70 years old Multiple Sclerosis patients
  • EDSS score: 5.5-7.5
  • Being oriented and cooperated
  • Mini-mental score ≥24/30

Exclusion Criteria

  • Modified Ashworth >3 in lower extremity muscles
  • Cognitive impairment
  • Botox injection within last 6-months
  • Having another neurological disease
  • Pregnancy or breast-feeding
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03801473). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search